Bilateral Meetings

  • Thursday 10:30 - 12:30
  • Thursday 14:30 - 17:30
DescriptionSTABVIDA is a genetic company. STAB VIDA has an exclusive line of genetics and genomics products and services. STAB VIDA has extensive experience in sequencing technologies (Sanger and NGS) as well as bioinformatics analysis of the data produced. We currently offer the widest range of diagnostic tests with a genetic basis in the market making the detection of mutations in all (using any of our 18,000+ genes) genes that are associated with hereditary genetic pathologies through the technologies of NGS, SANGER, MLPA / qPCR. Delivery time depends on the complexity of the test ranging from 3 to 7 weeks. In addition to the analysis of mutations, we also offer the report with the clinical interpretation. The tests are valid for diagnosis. These genetic tests meet high standards of quality, guaranteeing results of confidence, in several medical areas such as oncology, neurology, endocrinology and cardiology, among many others. STAB VIDA has focused its efforts on investigating exomas for the discovery of disease markers, diagnosis and appropriate treatment choice.
Organization Type Company